Cantero-García, N.; Flores-Burgess, A.; Ladrón de Guevara-Miranda, D.; Serrano, A.; García-Durán, L.; Puigcerver, A.; Fuxe, K.; Narváez, J.Á.; Santín, L.J.; Díaz-Cabiale, Z.;
et al. The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression. Biomedicines 2022, 10, 412.
https://doi.org/10.3390/biomedicines10020412
AMA Style
Cantero-García N, Flores-Burgess A, Ladrón de Guevara-Miranda D, Serrano A, García-Durán L, Puigcerver A, Fuxe K, Narváez JÁ, Santín LJ, Díaz-Cabiale Z,
et al. The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression. Biomedicines. 2022; 10(2):412.
https://doi.org/10.3390/biomedicines10020412
Chicago/Turabian Style
Cantero-García, Noelia, Antonio Flores-Burgess, David Ladrón de Guevara-Miranda, Antonia Serrano, Laura García-Durán, Araceli Puigcerver, Kjell Fuxe, José Ángel Narváez, Luis Javier Santín, Zaida Díaz-Cabiale,
and et al. 2022. "The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression" Biomedicines 10, no. 2: 412.
https://doi.org/10.3390/biomedicines10020412
APA Style
Cantero-García, N., Flores-Burgess, A., Ladrón de Guevara-Miranda, D., Serrano, A., García-Durán, L., Puigcerver, A., Fuxe, K., Narváez, J. Á., Santín, L. J., Díaz-Cabiale, Z., & Millón, C.
(2022). The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression. Biomedicines, 10(2), 412.
https://doi.org/10.3390/biomedicines10020412